Renaissance Capital logo

Onconova Therapeutics Priced, Nasdaq: ONTX

Biotech focused on developing drug candidates for cancer and related diseases.

Industry: Health Care

First Day Return: +32.5%

Biotech focused on developing drug candidates for cancer and related diseases.
IPO Data
IPO Date 07/24/2013
Offer Price IPO Intelligence Only
Price Range IPO Intelligence Only
Offer Shares (mm) IPO Intelligence Only
Deal Size ($mm) $78
Lock-Up Date IPO Intelligence Only
Street Research IPO Intelligence Only
Underwriters
IPO Intelligence Only
Company Data
Headquarters Newtown, PA, United States
Founded 1998
Employees at IPO 56
Website www.onconova.com

Onconova Therapeutics (ONTX) Performance

Created with Highcharts 10.3.2Chart context menuONTX vs. IPO Index (IPOUSA)2014201520162017201820192020202120222023202420250%+ 200%+ 400%-200%View 5 days5dView 1 month1mView 3 months3mView year to dateYTDView 1 year1yView allAllRenaissance IPO IndexOur ETF tracks the IPO Index